Characteristic N = 661
Did.you.complete.a.laryngology.fellowship.
    No 4 (6.1%)
    Yes 61 (92%)
    Yes, I consent to participate in this study 1 (1.5%)
Approximately.how.many.years.have.you.been.practicing. 13 (10, 21)
    Unknown 1
Do.you.see.patients.with.laryngeal.cancer.
    Yes 66 (100%)
Approximately.how.many.laryngeal.cancer.patients.do.you.see.per.year.
    0-10 16 (24%)
    20-Nov 31 (47%)
    21-30 12 (18%)
    40 7 (11%)
Approximately.how.many.of.these.patients.are.early.stage..T1.T2..
    0-25% 4 (6.1%)
    25-50% 3 (4.5%)
    50-75% 26 (39%)
    75-100% 33 (50%)
How.often.to.you.recommend.chest.imaging.for.METASTATIC.disease.in.early.laryngeal.cancer.patients.
     1 (1.5%)
    1 - Never 18 (27%)
    2 - Rarely 14 (21%)
    3 - Sometimes 7 (11%)
    4 - Most of the time 7 (11%)
    5 - Always 19 (29%)
What.is.your.imaging.modality.of.choice.for.METASTATIC.disease.screening.
     18 (27%)
    Chest X-ray 4 (6.1%)
    Low-dose CT chest 23 (35%)
    Non-contrast CT chest 10 (15%)
    PET/CT 11 (17%)
How.familiar.are.you.with.USPSTF.lung.cancer.screening.guidelines.
     1 (1.5%)
    1 - Not familiar at all 22 (33%)
    2 - Moderately unfamiliar 18 (27%)
    3 - Somewhat familiar 16 (24%)
    4 - Moderately familiar 4 (6.1%)
    5 - Very familiar 5 (7.6%)
How.often.do.you.recommend.chest.imaging.for.LUNG.CANCER.screening.in.those.who.meet.USPSTF.guidelines.based.on.their.smoking.history.
     2 (3.0%)
    1- Never 18 (27%)
    2 - Rarely 8 (12%)
    3 - Sometimes 11 (17%)
    4 - Most of the time 15 (23%)
    5 - Always 12 (18%)
What.is.your.imaging.modality.of.choice.for.these.lung.cancer.screenings.
     19 (29%)
    Chest X-ray 5 (7.6%)
    Low-dose CT chest 32 (48%)
    Non-contrast CT chest 8 (12%)
    PET/CT 2 (3.0%)
1 n (%); Median (IQR)